173 related articles for article (PubMed ID: 22376231)
1. The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis.
Levin I; Petrasek J; Szabo G
Alcohol Clin Exp Res; 2012 Aug; 36(8):1397-406. PubMed ID: 22376231
[TBL] [Abstract][Full Text] [Related]
2. Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis.
De Minicis S; Seki E; Paik YH; Osterreicher CH; Kodama Y; Kluwe J; Torozzi L; Miyai K; Benedetti A; Schwabe RF; Brenner DA
Hepatology; 2010 Oct; 52(4):1420-30. PubMed ID: 20690191
[TBL] [Abstract][Full Text] [Related]
3. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.
Hritz I; Mandrekar P; Velayudham A; Catalano D; Dolganiuc A; Kodys K; Kurt-Jones E; Szabo G
Hepatology; 2008 Oct; 48(4):1224-31. PubMed ID: 18792393
[TBL] [Abstract][Full Text] [Related]
4. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice.
Mandrekar P; Ambade A; Lim A; Szabo G; Catalano D
Hepatology; 2011 Dec; 54(6):2185-97. PubMed ID: 21826694
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
Zhang W; Sun Q; Zhong W; Sun X; Zhou Z
Alcohol Clin Exp Res; 2016 May; 40(5):988-99. PubMed ID: 27062444
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice.
Inokuchi S; Tsukamoto H; Park E; Liu ZX; Brenner DA; Seki E
Alcohol Clin Exp Res; 2011 Aug; 35(8):1509-18. PubMed ID: 21463341
[TBL] [Abstract][Full Text] [Related]
7. Loss of functional NADPH oxidase 2 protects against alcohol-induced bone resorption in female p47phox-/- mice.
Mercer KE; Sims CR; Yang CS; Wynne RA; Moutos C; Hogue WR; Lumpkin CK; Suva LJ; Chen JR; Badger TM; Ronis MJ
Alcohol Clin Exp Res; 2014 Mar; 38(3):672-82. PubMed ID: 24256560
[TBL] [Abstract][Full Text] [Related]
8. Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation.
Jeon S; Scorletti E; Dempsey J; Buyco D; Lin C; Saiman Y; Bayen S; Harkin J; Martin J; Hooks R; Ogretmen B; Argemi J; Melo L; Bataller R; Carr RM
Mol Metab; 2023 Dec; 78():101804. PubMed ID: 37714377
[TBL] [Abstract][Full Text] [Related]
9. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.
Wu WB; Chen YY; Zhu B; Peng XM; Zhang SW; Zhou ML
Biochimie; 2015 Aug; 115():86-92. PubMed ID: 26025474
[TBL] [Abstract][Full Text] [Related]
10. SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy.
You Y; Li WZ; Zhang S; Hu B; Li YX; Li HD; Tang HH; Li QW; Guan YY; Liu LX; Bao WL; Shen X
J Hepatol; 2018 Jul; 69(1):129-141. PubMed ID: 29452206
[TBL] [Abstract][Full Text] [Related]
11. Hepatocytes produce TNF-α following hypoxia-reoxygenation and liver ischemia-reperfusion in a NADPH oxidase- and c-Src-dependent manner.
Spencer NY; Zhou W; Li Q; Zhang Y; Luo M; Yan Z; Lynch TJ; Abbott D; Banfi B; Engelhardt JF
Am J Physiol Gastrointest Liver Physiol; 2013 Jul; 305(1):G84-94. PubMed ID: 23639811
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice.
Nath B; Levin I; Csak T; Petrasek J; Mueller C; Kodys K; Catalano D; Mandrekar P; Szabo G
Hepatology; 2011 May; 53(5):1526-37. PubMed ID: 21520168
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis.
Im KH; Saeed WK; Kim EB; Lee AH; Kim JE; Lee SM; Hanning X; Kim HS; Jun DW; Yoon EL
Dig Dis Sci; 2024 May; 69(5):1701-1713. PubMed ID: 38551744
[TBL] [Abstract][Full Text] [Related]
14. Luteolin alleviates alcoholic liver disease induced by chronic and binge ethanol feeding in mice.
Liu G; Zhang Y; Liu C; Xu D; Zhang R; Cheng Y; Pan Y; Huang C; Chen Y
J Nutr; 2014 Jul; 144(7):1009-15. PubMed ID: 24828027
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-α and prevents early alcohol-induced liver injury in mice.
Ge X; Leung TM; Arriazu E; Lu Y; Urtasun R; Christensen B; Fiel MI; Mochida S; Sørensen ES; Nieto N
Hepatology; 2014 Apr; 59(4):1600-16. PubMed ID: 24214181
[TBL] [Abstract][Full Text] [Related]
16. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.
Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T
Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218
[TBL] [Abstract][Full Text] [Related]
17. Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice.
Lu Y; Wu D; Wang X; Ward SC; Cederbaum AI
Free Radic Biol Med; 2010 Nov; 49(9):1406-16. PubMed ID: 20692331
[TBL] [Abstract][Full Text] [Related]
18. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.
Csak T; Velayudham A; Hritz I; Petrasek J; Levin I; Lippai D; Catalano D; Mandrekar P; Dolganiuc A; Kurt-Jones E; Szabo G
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G433-41. PubMed ID: 21233280
[TBL] [Abstract][Full Text] [Related]
19. Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells.
Petrasek J; Dolganiuc A; Csak T; Nath B; Hritz I; Kodys K; Catalano D; Kurt-Jones E; Mandrekar P; Szabo G
Hepatology; 2011 Feb; 53(2):649-60. PubMed ID: 21274885
[TBL] [Abstract][Full Text] [Related]
20.
Zhang YH; Ma Q; Ding P; Li J; Chen LL; Ao KJ; Tian YY
Yonsei Med J; 2018 Nov; 59(9):1064-1071. PubMed ID: 30328321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
